Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Innate-like cells and protection of the young animal
- Waves of gamma-delta cell development
- Testing immunological mechanisms
- Th1 protection by alpha-beta T cells
- T-cells in young mice
- Gamma-delta cells confer young mice resistance
- Working model for gamma-delta cells
- Studying the situation in human neonates
- Cytokines production by different T-cells
- Precocious activation of gamma-delta T cells
- Section 3: interim conclusions
- Toll like receptors and their ligands
- Gamma-delta cells in pre-term neonates (1)
- Gamma-delta cells in pre-term neonates (2)
- Summary of section 3
- Ligands for innate-like / unconventional T cells
- Ligands and "unconventional MHC" - iNKT
- Ligands and "unconventional MHC" - MAIT cells
- Ligands and "unconventional MHC" - gamma-delta
- Unconventional T cell "ligands"
- "New Tac" FVB mice
- Characterization of the mutant strain
- The Taconic defect is in the stromal compartment
- Skint1 structure and possible topology
- The efficacy of Skint-1
- What is Skint-1?
- Skint-1 expressed in the thymus and skin
- Summary of gamma-delta cell selection
- Is Skint-1 a positively selecting agonist?
- Molecules that regulate unconventional T cells
- Recognition by human gamma-delta T cells
- Peripheral gamma-delta cell response to infection
- Non-peptide activators produced by parasites
- Sources of activators for human gamma-delta cells
- Clinical trial: Francesco Dieli - Palermo
- Cell subset dynamics in response to treatment
- Gamma-delta responses in a cancer patient
- Data so far... clinical outcome
- Human peripheral blood Vgamma9Vdelta2+ cells
Topics Covered
- Innate-like cells and protection of the young animal
- Waves of gamma-delta cell development
- Th1 protection by alpha-beta T cells
- Gamma-delta cells confer young mice resistance
- Studying the situation in human neonates
- Cytokines production by different T-cells
- Toll like receptors and their ligands
- Gamma-delta cells in pre-term neonates
- Ligands and "unconventional MHC"
- "new Tac" FVB mice
- Characterization of the mutant strain
- The Taconic defect is in the stromal compartment
- Skint1 structure and possible topology
- Is Skint-1 a positively selecting agonist?
- Molecules that regulate unconventional T cells
- Recognition by human gamma-delta T cells
- Peripheral gamma-delta cell response to infection
- Non-peptide activators produced by parasites
- Clinical trial: Francesco Dieli
- Palermo
- Cell subset dynamics in response to treatment
- Gamma-delta responses in a caner patient
Talk Citation
Hayday, A. (2009, July 15). Innate-like lymphocytes 2 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/SJWD6896.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Adrian Hayday has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Innate-like lymphocytes 2
Published on July 15, 2009
41 min